News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

OncoDaily GI
OncoDaily Breast
OncoDaily IO
OncoDaily Lung
OncoDaily RT
OncoDaily GU
OncoDaily AI
OncoDaily Biotech

Services
Privacy Policy
Contact Us

Aug / 2026

August 2026
M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

« Jul

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Community Oncology Global Congress 2026

Highlights From Community Oncology Global Congress 2026, Day 2

The State of Oncology in 2026 With ZS

Natalie Harp’s Cancer Story: The Controversial Bone Cancer Case, Trump, and Right to Try

FDA Approves Takeda’s Mimrylo (Rusfertide) for Polycythemia Vera

Registration Open: ODC Life Sciences Invites Clinical Development Leaders to ‘Brazil Unlocked’ in Cambridge, Massachusetts

POEMS Syndrome: The Small Plasma Cell Clone Behind a Big Multisystem Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

message

Oct 12, 2024 11:00 am

Blog Posts

SIOP Europe – A Virtual Awareness Wall dedicated to inspiring the paediatric oncology community

Headlines

FDA Approves Daraxonrasib: Here is What Oncologists Have to Say

Oct 12, 2024

Ryan Schoenfeld: Personalized mRNA Vaccines Mark a Turning Point in Cancer Immunotherapy

Oct 12, 2024

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Oct 12, 2024

Multiple Myeloma in 2026: Comprehensive Clinical Update

Oct 12, 2024

Douglas Flora: Making Mental Health Part of Cancer Care

Oct 12, 2024

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer cancer care ASCO fight against cancer Lung cancer Global fight against cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center clinical trials cancer awareness colorectal cancer prostate cancer FDA Research Childhood Cancer UICC AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Dana-Farber Cancer Institute American Cancer Society Robert Orlowski AI American Society of Clinical Oncology SIOP European Cancer Organisation Precision Oncology NCI National Cancer Institute Myeloma Paper of the Day cervical cancer WHO Paolo Tarantino radiotherapy Myeloma Vivek Subbiah IASLC bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}